First Citizens BancShares, Inc. Peer Comparison
| Metric | Value | Ranking | ||||||
|---|---|---|---|---|---|---|---|---|
| Market Cap | $25.2 Billion | 2/6 | FCNCP $25.7B |
FCNCO $25.2B |
FITBO $15.1B |
FULTP $3.3B |
DCOMP $1.2B |
TCBIO $947.9M |
| Gross Margin | 100% | 1/6 | FCNCO 100% |
FITBO 100% |
DCOMP 100% |
FCNCP 100% |
TCBIO 100% |
FULTP 0% |
| Profit Margin | 29% | 1/6 | FCNCO 29% |
FITBO 29% |
FCNCP 29% |
TCBIO 25% |
FULTP 0% |
DCOMP -36% |
| EBITDA margin | 0% | 1/6 | FCNCO 0% |
FITBO 0% |
DCOMP 0% |
FCNCP 0% |
TCBIO 0% |
FULTP -100% |
| Quarterly Revenue | $2.4 Billion | 1/6 | FCNCO $2.4B |
FCNCP $2.4B |
FITBO $2.1B |
TCBIO $283.7M |
DCOMP $57.2M |
FULTP $0 |
| Quarterly Earnings | $700.0 Million | 1/6 | FCNCO $700.0M |
FCNCP $700.0M |
FITBO $620.0M |
FULTP $86.2M |
TCBIO $71.0M |
DCOMP -$20.4M |
| Quarterly Free Cash Flow | $678.0 Million | 1/6 | FCNCO $678.0M |
FCNCP $678.0M |
DCOMP $87.0M |
TCBIO $11.0M |
FITBO -$228.0M |
FULTP -$0 |
| Trailing 4 Quarters Revenue | $13.6 Billion | 1/6 | FCNCO $13.6B |
FCNCP $13.6B |
FITBO $12.2B |
TCBIO $1.7B |
FULTP $842.9M |
DCOMP $570.2M |
| Trailing 4 Quarters Earnings | $2.8 Billion | 1/6 | FCNCO $2.4B |
FCNCP $2.4B |
FITBO $2.1B |
TCBIO $283.7M |
DCOMP $57.2M |
FULTP -$0 |
| Quarterly Earnings Growth | 36% | 2/6 | TCBIO 348% |
FCNCO 36% |
FCNCP 36% |
FULTP 34% |
FITBO 17% |
DCOMP -225% |
| Annual Earnings Growth | 0% | 2/6 | FULTP 15% |
FCNCO 0% |
FCNCP 0% |
FITBO -8% |
DCOMP -53% |
TCBIO -61% |
| Quarterly Revenue Growth | -36% | 2/6 | TCBIO 15% |
FCNCO -36% |
FCNCP -36% |
FITBO -37% |
DCOMP -64% |
FULTP -100% |
| Annual Revenue Growth | 20% | 3/6 | DCOMP 38% |
FITBO 24% |
FCNCO 20% |
FCNCP 20% |
TCBIO 9% |
FULTP -30% |
| Cash On Hand | $22.2 Billion | 1/6 | FCNCO $22.2B |
FCNCP $22.2B |
TCBIO $3.2B |
FITBO $3.0B |
DCOMP $1.3B |
FULTP $295.2M |
| Short Term Debt | $0 | 4/6 | FITBO $4.2B |
TCBIO $885.0M |
DCOMP $50.0M |
FCNCO -$0 |
FCNCP -$0 |
FULTP -$0 |
| Long Term Debt | $37.0 Billion | 1/6 | FCNCO $37.0B |
FCNCP $37.0B |
FITBO $14.3B |
DCOMP $929.3M |
TCBIO $660.3M |
FULTP $0 |
| PE | 9.08 | 5/6 | DCOMP 42.89 |
TCBIO 12.23 |
FULTP 10.37 |
FCNCP 9.26 |
FCNCO 9.08 |
FITBO 6.51 |
| PS | 1.85 | 4/6 | FULTP 3.97 |
DCOMP 2.19 |
FCNCP 1.88 |
FCNCO 1.85 |
FITBO 1.24 |
TCBIO 0.57 |
| PB | 1.13 | 2/6 | FCNCP 1.16 |
FCNCO 1.13 |
DCOMP 0.89 |
FITBO 0.77 |
FULTP 0.47 |
TCBIO 0.28 |
| PC | 1.14 | 4/6 | FULTP 11.34 |
FITBO 5.00 |
FCNCP 1.16 |
FCNCO 1.14 |
DCOMP 0.97 |
TCBIO 0.30 |
| Liabilities to Equity | 9.06 | 3/6 | FITBO 9.84 |
DCOMP 9.28 |
FCNCO 9.06 |
FCNCP 9.06 |
TCBIO 8.12 |
FULTP 0.70 |
| ROA | 0.01 | 1/6 | FCNCO 1% | FITBO 1% | FCNCP 1% | FULTP 1% | DCOMP 0% | TCBIO 0% |
| ROE | 0.12 | 1/6 | FCNCO 12% |
FITBO 12% |
FCNCP 12% |
DCOMP 2% |
TCBIO 2% |
FULTP 1% |
| Current Ratio | 1.11 | 3/6 | FULTP 1.33 |
TCBIO 1.12 |
FCNCO 1.11 |
DCOMP 1.11 |
FCNCP 1.11 |
FITBO 1.10 |
| Quick Ratio | 0.28 | 2/6 | DCOMP 42.89 |
TCBIO 12.23 |
FULTP 10.37 |
FCNCP 9.26 |
FCNCO 9.08 |
FITBO 6.51 |
| Long Term Debt to Equity | 1.67 | 1/6 | FCNCO} 1.67 |
FCNCP} 1.67 |
FITBO} 0.73 |
DCOMP} 0.67 |
TCBIO} 0.20 |
FULTP} 0.00 |
| Debt to Equity | 1.67 | 1/6 | FCNCO 1.67 |
FCNCP 1.67 |
FITBO 0.94 |
DCOMP 0.70 |
TCBIO 0.46 |
FULTP 0.00 |
| Burn Rate | 28.37 | 1/6 | FCNCO 28.37 |
FCNCP 28.37 |
DCOMP 18.31 |
TCBIO 18.05 |
FITBO 3.04 |
FULTP -3.42 |
| Cash to Cap | 0.88 | 3/6 | TCBIO 3.36 |
DCOMP 1.03 |
FCNCO 0.88 |
FCNCP 0.86 |
FITBO 0.20 |
FULTP 0.09 |
| CCR | 0.97 | 1/6 | FCNCO 0.97 |
FCNCP 0.97 |
TCBIO 0.15 |
FITBO -0.37 |
DCOMP -4.26 |
FULTP |
| EV to EBITDA | -1.00 | 2/6 | FULTP} 999999.99 |
FCNCO} -1.00 |
FITBO} -1.00 |
DCOMP} -1.00 |
FCNCP} -1.00 |
TCBIO} -1.00 |
| EV to Revenue | -1.00 | 2/6 | FULTP 3.62 |
FCNCO -1.00 |
FITBO -1.00 |
DCOMP -1.00 |
FCNCP -1.00 |
TCBIO -1.00 |